YOLFTbeta
Co-Diagnostics, Inc. Common Stock

Co-Diagnostics, Inc. Common Stock

CODX · NASDAQ · Healthcare / Medical Devices

0.2586USD-0.01 (-4.12%)

Price History

Full chart

Market Stats

Previous Close0.2697
Open0.2692
Day Range0.245 – 0.2692
52-Week Range0.9057 – 46.50
Volume591.94K
Market Cap8.03M
P/E (TTM)0.00
Forward P/E15.36
EPS-25.89
Dividend Yield0.00%
Beta2.85
50-Day Avg1.45
200-Day Avg3.07

About

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Dwight H. Egan
  • Employees115
  • Headquarters2401 S. Foothill Drive, Salt Lake City, UT, United States, 84109, USA
  • Websitehttps://co-dx.com

Leadership

  • Mr. Dwight H. EganChairman, CEO & President · b. 1953
  • Mr. Richard David AbbottPresident · b. 1972
  • Mr. David NielsenChief Operating Officer
  • Mr. Christopher ThurstonChief Technology Officer
  • Dr. Wesley C. Lindsey MBA, Ph.D.Chief Scientific Officer
  • Mr. Andrew BensonHead of Investor Relations
  • Dr. Mayuranki Almaula Ph.D.Senior Vice President of Overseas Operations & Strategic Alliances
  • Mr. Seth EganChief Commercialization Officer & Strategy Officer

Financials

Income Statement

Currency: USD2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue010.00K07.66K39.91K214.97K74.55M97.89M34.22M6.81M3.92M622.49K
Growth (%)---100.00%-+420.90%+438.63%+34579.90%+31.30%-65.04%-80.09%-42.53%-84.10%
Cost of Revenue043.14K37.49K3029.39K112.43K16.59M11.57M5.48M4.18M999.12K222.38K
Gross Profit010.00K-37.49K7.36K30.52K102.54K57.96M86.31M28.74M2.63M2.92M400.11K
Gross Margin-100.00%-96.06%76.47%47.70%77.75%88.18%83.98%38.57%74.48%64.28%
Operating Expense1.03M1.98M1.65M4.57M6.15M6.00M16.27M40.25M55.72M45.33M43.00M31.68M
Operating Income-1.03M-1.97M-1.69M-4.56M-6.12M-5.89M41.69M46.06M-26.98M-42.71M-40.08M-31.28M
Operating Margin--19679.79%--59567.57%-15328.65%-2741.61%55.93%47.06%-78.85%-626.92%-1023.75%-5025.53%
EBITDA-1.02M-1.92M-1.65M-6.60M-6.09M-6.02M41.83M45.97M-10.31M-36.88M-36.20M-47.41M
EBITDA Margin--19248.39%--86177.75%-15248.96%-2801.84%56.11%46.96%-30.13%-541.40%-924.72%-7615.41%
Net Income-1.05M-2.04M-1.93M-6.96M-6.27M-6.20M42.48M36.66M-14.24M-35.33M-37.64M-46.90M
Net Income Margin--20431.68%--90827.88%-15714.27%-2882.00%56.98%37.45%-41.61%-518.68%-961.37%-7533.62%
R&D311.48K806.91K731.47K1.00M1.36M1.37M3.19M14.96M17.44M22.96M20.98M19.14M
R&D as % of Total Revenue-8069.13%-13092.76%3410.47%637.95%4.27%15.29%50.96%337.09%535.86%3074.31%
Interest Expense075.19K240.72K310.23K134.95K106.44K175473.51K14.88M---
Interest Expense % of Total Revenue-751.89%-4048.98%338.12%49.51%0.00%0.48%43.49%---

Balance Sheet

Currency: USD2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets259.85K370.93K1.30M4.66M1.55M2.22M71.24M160.03M123.09M95.32M64.00M24.74M
Total Liabilities121.22K1.52M4.29M811.80K2.61M478.07K4.54M25.56M8.57M9.31M9.69M4.11M
Total Equity138.63K-1.15M-2.99M3.85M-1.06M1.74M66.70M134.48M114.52M86.01M54.31M20.63M
Cash214.45K33.80K998.74K3.53M950.24K893.14K42.98M88.61M22.97M14.92M2.94M11.88M
Total Debt-1.01M3.39M-1.91M---347.92K2.99M2.15M1.24M
Net Debt-214.45K977.73K2.40M-3.53M958.34K-893.14K-42.98M-88.61M-22.63M-11.93M-784.37K-10.65M

Cash Flow

Currency: USD2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-925.23K-1.53M-1.31M-3.21M-4.08M-5.53M28.17M41.08M6.57M-22.08M-29.16M-29.14M
Investing Cash Flow-195.36K-110.27K-12.24K-189.31K-380.34K-435.25K-5.82M4.10M-58.17M15.39M17.07M26.27M
Financing Cash Flow1.15M1.46M2.29M5.94M1.88M5.90M19.74M450.40K-14.03M-1.36M103.91K11.81M
Capital Expenditure11.89K118.47K12.24K129.31K41.34K113.25K774.40K669.46K1.43M1.37M748.35K700.05K
Free Cash Flow-937.11K-1.65M-1.32M-3.34M-4.12M-5.64M27.39M40.41M5.14M-23.45M-29.90M-29.84M
Dividends Paid---0--------
FCF to OCF101.28%107.74%100.93%104.03%101.01%102.05%97.25%98.37%78.27%106.18%102.57%102.40%
Dividend Paid to FCF---0.00%--------

Earnings

Report DateJul 10, 2017Nov 14, 2017Mar 28, 2018May 14, 2018Aug 10, 2018Nov 14, 2018Dec 31, 2018May 14, 2019Aug 14, 2019Nov 12, 2019Mar 30, 2020May 14, 2020Aug 13, 2020Nov 16, 2020Mar 25, 2021May 13, 2021Aug 12, 2021Nov 11, 2021Mar 24, 2022May 12, 2022Aug 11, 2022Nov 10, 2022Mar 16, 2023May 11, 2023Aug 10, 2023Nov 9, 2023Mar 14, 2024May 9, 2024Aug 8, 2024Nov 7, 2024Mar 12, 2025May 8, 2025Aug 14, 2025Nov 13, 2025Mar 19, 2026May 14, 2026Aug 13, 2026Nov 12, 2026
EPS Estimate0.00------0.13-2.40-1.65-2.25-0.09-1.2019.5021.150.486.006.606.300.125.102.10-1.00-0.15-7.20-7.20-8.70-0.20-6.30-10.20-9.90-0.34-9.90-7.50-5.70-0.13-3.75-3.00-
EPS Actual-0.07-0.33-0.12-0.11-0.11-0.13-0.15-2.70-2.40-3.00-0.09-1.5012.9015.900.457.809.9011.400.257.64-2.91-2.38-0.68-6.91-9.50-6.54-0.50-9.81-7.50-9.82-0.38-7.72-7.01-4.66-4.44-4.09-1.46-
Surprise-------15.38%-12.50%-45.45%-33.33%0.00%-25.00%-33.85%-24.82%-6.25%30.00%50.00%80.95%108.33%49.80%-238.57%-138.00%-353.33%4.03%-31.94%24.83%-150.00%-55.71%26.47%0.81%-11.12%22.02%6.53%18.25%-3314.46%-9.07%51.33%-
Timing--After-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hours-

Key Statistics & Ratios

Market Cap8.03M
Enterprise Value5.76M
Trailing P/E0.00
Forward P/E15.36
PEG Ratio0.00
Price / Sales11.13
Price / Book0.60
EPS-25.89
Book Value2.61
Revenue (TTM)721.39K
Gross Profit (TTM)313.63K
EBITDA-29.09M
Profit Margin0.00%
Operating Margin-3732.47%
Return on Equity-174.77%
Return on Assets-59.63%
Shares Outstanding6.98M
Shares Float6.13M
Beta2.85
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 2 analystsTarget 4.00
  • Strong Buy
    1
  • Hold
    1

Ownership Breakdown

Institutions
10.54%
Insiders
2.07%
Retail / Other
87.39%

Top Institutional Holders

  • Private Asset Group LLC
    39.39K0.56%
  • Millennium Management LLC
    32.00K0.46%
  • UBS Group AG
    7.37K0.11%
  • Global Retirement Partners, LLC.
    1000.00%
  • Morgan Stanley - Brokerage Accounts
    880.00%
  • Wells Fargo & Co
    810.00%
  • SBI Securities Co Ltd
    580.00%
  • JPMorgan Chase & Co
    500.00%
  • Heritage Wealth Advisors, LLC
    170.00%
  • Western Wealth Management, LLC
    170.00%
  • Advisor Group Holdings, Inc.
    100.00%
  • Goss Wealth Management LLC
    60.00%
  • HARBOUR INVESTMENTS, INC.
    20.00%
  • Citigroup Inc
    10.00%
  • Vanguard Fiduciary Trust Co
    10.00%
  • State Street Corp
    00.00%
  • Susquehanna International Group, LLP
    00.00%

Top Fund Holders

  • Fidelity Extended Market Index
    19.01K0.27%
  • Fidelity Series Total Market Index
    6.57K0.09%
  • Fidelity Total Market Index
    4.34K0.06%

Stock Splits

  • Jan 2, 20261:30